Mettler-Toledo International Inc
General ticker "MTD" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $26.6B
Mettler-Toledo International Inc follows the US Stock Market performance with the rate: 38.2%.
Estimated limits based on current volatility of 1.5%: low 1202.18$, high 1238.07$
Factors to consider:
- Company included in S&P500 list
- US accounted for 37.1% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1240.61$, 1701.08$]
- 2024-12-30 to 2025-12-30 estimated range: [1502.76$, 2011.25$]
Financial Metrics affecting the MTD estimates:
- Positive: Non-GAAP EPS, $ of 38.08 > 2.29
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Interest expense per share, $ of 3.54 > 0.74
- Positive: Operating profit margin, % of 30.41 > 19.51
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
Short-term MTD quotes
Long-term MTD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $3,717.93MM | $3,919.71MM | $3,788.31MM |
| Operating Expenses | $2,720.09MM | $2,784.17MM | $2,636.41MM |
| Operating Income | $997.84MM | $1,135.54MM | $1,151.90MM |
| Non-Operating Income | $-48.48MM | $-64.95MM | $-178.17MM |
| Interest Expense | $43.24MM | $55.39MM | $77.37MM |
| R&D Expense | $169.77MM | $177.12MM | $185.28MM |
| Income(Loss) | $949.36MM | $1,070.59MM | $973.73MM |
| Taxes | $180.38MM | $198.09MM | $184.95MM |
| Profit(Loss) | $768.99MM | $872.50MM | $788.78MM |
| Stockholders Equity | $171.42MM | $24.79MM | $-149.94MM |
| Inventory | $414.54MM | $441.69MM | $385.87MM |
| Assets | $3,326.80MM | $3,492.39MM | $3,355.55MM |
| Operating Cash Flow | $908.83MM | $859.07MM | $965.87MM |
| Capital expenditure | $107.58MM | $121.24MM | $105.32MM |
| Investing Cash Flow | $-314.11MM | $-139.40MM | $-131.69MM |
| Financing Cash Flow | $-590.55MM | $-716.04MM | $-859.59MM |
| Earnings Per Share* | $33.25 | $38.79 | $36.10 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.